Clinical Trial Update: An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial updating early bactericidal activity, safety, and tolerability of GSK3036656 in drug-sensitive pulmonary tuberculosis completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK3036656

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-26